Marc Lavielle, Ph.D. 

Professor of Mathematics at the University Paris-Sud (Orsay) 

January 13 & 14, 2011
MONOLIX 3.2 Hands on Workshop

Principal Scientist, XOMA, Berkeley, CA - CEO, POP-Pharm, Inc., Berkeley, CA

September 9, 2009
S-ADAPT Introductory Workshop:
Population Data Analysis using Monte-Carlo Parametric Expectation Maximization Algorithm (MCPEM) in S-ADAPT

Steve Barriere, Pharm.D.
VP of Clinical and Medical Affairs, Theravance and Clinical Professor, UCSF

June 12, 2009
Use of PK/PD in Anti-Infective Drug Development ‐ The Telavancin Story

BAPKPD Poster Social Event

March 6, 2009

In this event, posters that have already been presented at other meetings get a 'second chance' to be displayed, for the benefit of the scientific community of the Bay Area.  The posters and podia will showcase the use of PK/PD modeling and simulation in drug research, safety assessment, clinical pharmacology, clinical trial design, and regulatory dossiers.

Ritu Lal, Ph.D.,
Executive Director, Clinical Pharmacology, PK/ADME, Xenoport, Inc.

December 12, 2008

Clinical Pharmacology of Gabapentin Enacarbil (XP13512): A Novel Transported Prodrug of Gabapentin

Joint Half Day PK/PD Workshop with CACO (4 speakers)

Oct. 9, 2008

"Introduction to PK/PD Modeling and Case Studies"

Emil Samara, Ph.D. (PharmaPolaris),

Amita Joshi, Ph.D. (Genentech),

Sanjeev Thohan, Ph.D. (Exelixis)

TJ Carrothers, Ph.D. (Pharsight). 

Deanna Kroetz, Ph.D.

Professor of Biopharmaceutical Sciences and Pharmaceutical Chemistry,

University of California, San Francisco

September 11, 2008

"ABC Transporter Pharmacogenetics: Should We Care in Drug Development?"

Terrence Blaschke, M.D.
Departments of Medicine and Molecular Pharmacology Stanford University School of Medicine
Division of Clinical Pharmacology - Department of Med., Stanford Medical Center

June 11, 2008

"Surrogate Marker Development"

Donald Stanksi, M.D.
Vice President and Global Head, Modeling and Simulation Novartis Pharma AG, and Professor of Anesthesia (Emeritus) Stanford University

October 11, 2007
"Modeling and Simulation at Novartis: Implementing Model-Based Drug Development"

Tom Ludden, Ph.D.
Vice President, Pharmacometric Research & Development
ICON Development Solutions

June 27 2007

Institutionalization of Quant-Based Decision-Making

Jeffrey Barrett, Ph.D., FCP
Research Associate Professor, Pediatrics and Director, Pediatric Pharmacology Research Unit, Laboratory for Applied PK/PD

Clinical Pharmacology & Therapeutics

The Children's Hospital of Philadelphia

April 4, 2007
"Evolving Relevant Data Signatures for Compounds Utilized in Pediatric Pharmacotherapy: M&S Approach to Translational Research "

BAPKPD Poster Social Event

February 15, 2007

In this event, posters that have already been presented at other meetings get a 'second chance' to be displayed, for the benefit of the scientific community of the Bay Area.  The posters and podia will showcase the use of PK/PD modeling and simulation in drug research, safety assessment, clinical pharmacology, clinical trial design, and regulatory dossiers.